when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

6,918 products tracked · 322 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

Marketed
pembrolizumab
Keytruda (pembrolizumab)
Merkel Cell Carcinoma$MRK Merck & Co., Inc.125 cat
Marketed
nivolumab
Opdivo (nivolumab)
Colorectal Cancer Bristol-Myers Squibb Co86 cat
Marketed
atezolizumab
Tecentriq (atezolizumab)
Muscle Invasive Bladder Cancer (MIBC) F. Hoffmann-La Roche Ltd41 cat
Marketed

← prev

page 1 of 11

131

MEDROL (METHYLPREDNISOLONE)

no indication

$PFE PFIZER INC

34 cat

Marketed

Blincyto (blinatumomab)

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$AMGN AMGEN INC25 cat

Marketed

cabozantinib s-malate

Cometriq (cabozantinib s-malate)

Endometrial Cancer$EXEL EXELIXIS, INC.25 cat

Marketed

Venclexta (venetoclax)

Mantle Cell Lymphoma$ABBV AbbVie Inc.22 cat

Marketed

Libtayo (cemiplimab-rwlc)

Melanoma$REGN REGENERON PHARMACEUTICALS, INC.17 cat

Marketed

CALQUENCE (ACALABRUTINIB)

no indication$AZN ASTRAZENECA PLC13 cat

Marketed

asciminib hydrochloride

Scemblix (asciminib hydrochloride)

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)$NVS NOVARTIS AG13 cat

Marketed

Hemady (dexamethasone [INN])

Multiple Myeloma (Kahler Disease) Fera Pharmaceuticals LLC10 cat

Marketed

Methotrexate Sodium (methotrexate)

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$PFE PFIZER INC8 cat

Marketed

Truqap (capivasertib)

Human Epidermal Growth Factor Receptor 2 Negative Breast…$AZN ASTRAZENECA PLC5 cat

Marketed

Colon Cancer Armas Pharmaceuticals Inc3 cat

Marketed

cyclophosphamide

Cyclophosphamide (cyclophosphamide [INN])

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Long Grove Pharmaceuticals LLC3 cat

Marketed

Carboplatin Pfizer

Metastatic Ovarian Cancer$PFE PFIZER INC2 cat

Marketed

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Xspray Pharma AB2 cat

Marketed

Onureg (azacitidine)

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Bristol-Myers Squibb Co2 cat

Marketed

Yervoy (ipilimumab)

Esophageal Squamous Cell Carcinoma (ESCC) Bristol-Myers Squibb Co2 cat

Marketed

Bavencio (avelumab)

Merkel Cell Carcinoma EMD Serono Inc1 cat

Marketed

Zykadia (ceritinib)

Non-Small Cell Lung Cancer$NVS NOVARTIS AG1 cat

Marketed

Lynparza (olaparib)

Epithelial Ovarian Cancer AstraZeneca Pharmaceuticals LP1 cat

Marketed

Zoladex (goserelin)

Metrorrhagia (Abnormal Uterine Bleeding) TerSera Therapeutics LLC76 cat

Marketed

(daratumumab + hyaluronidase (human recombinant))

Darzalex Faspro ((daratumumab + hyaluronidase (human recombinant)-fihj))

Multiple Myeloma (Kahler Disease) Janssen Biotech Inc16 cat

Marketed

Zynyz (retifanlimab-dlwr)

Squamous Non-Small Cell Lung Cancer$INCY INCYTE CORP6 cat

Marketed

Jelmyto (mitomycin)

Transitional Cell Carcinoma (Urothelial Cell Carcinoma)$URGN UroGen Pharma Ltd.1 cat

Marketed

Efudex (fluorouracil)

Basal Cell Carcinoma (Basal Cell Epithelioma) Extrovis AG42 cat

Marketed

Elrexfio (elranatamab-bcmm)

Refractory Multiple Myeloma$PFE PFIZER INC8 cat

Marketed

Myleran (busulfan)

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Woodward Pharma Services LLC1 cat

Marketed

Prolia (denosumab)

Glucocorticoid-Induced Osteoporosis$AMGN AMGEN INC1 cat